You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
AstraZeneca
Johnson and Johnson
Dow
Colorcon

Last Updated: February 25, 2020

DrugPatentWatch Database Preview

Details for Patent: 9,480,652


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Which drugs does patent 9,480,652 protect, and when does it expire?

Patent 9,480,652 protects VARITHENA and is included in one NDA.

This patent has eight patent family members in eight countries.

Summary for Patent: 9,480,652
Title:Aerosol valve
Abstract: A steam-sterilizable aerosol valve has a valve body of polymeric material such as polyphenylene sulfone (PPSU) having an HDT (heat deflection temperature) at 1.8 MPa stress in the range of 200-275.degree. C. Such a valve has the ability to survive steam sterilization without significant degradation of properties or appearance.
Inventor(s): Harman; Anthony David (Henley-on-thames, GB)
Assignee: BTG INTERNATIONAL LIMITED (London, GB)
Application Number:12/083,871
Patent Claim Types:
see list of patent claims
Device; Compound; Use; Composition; Formulation;

Drugs Protected by US Patent 9,480,652

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Provensis VARITHENA polidocanol SOLUTION;INTRAVENOUS 205098-001 Nov 25, 2013 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,480,652

PCT Information
PCT FiledOctober 20, 2006PCT Application Number:PCT/GB2006/003916
PCT Publication Date:April 26, 2007PCT Publication Number: WO2007/045897

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Harvard Business School
Johnson and Johnson
Baxter
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.